Multimodal integration of plasma biomarkers, MRI, and genetic risk to predict cerebral amyloid burden in Alzheimer’s disease
Open Access
- 23 October 2025
- journal article
- Published by Elsevier in NeuroImage
- Vol. 322, 121550
Abstract
No abstract availableKeywords
Funding Information
- Hubei Key Laboratory of Mine Environmental Pollution Control and Remediation
- Natural Science Foundation of Beijing Municipality (L252087)
- Fundamental Research Funds for Central Universities of the Central South University (2017XTCX04)
- State Key Laboratory of Cognitive Neuroscience and Learning (CNLZD2101)
- State Key Laboratory of Cognitive Neuroscience and Learning (CNLZD2303)
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China (82301608)
- National Natural Science Foundation of China (32271145)
- National Natural Science Foundation of China (210510238)
- National Natural Science Foundation of China (81871425)
This publication has 58 references indexed in Scilit:
- CFATrans: Brain tumor segmentation from MRIs using Consecutive Fusion-Attention transformer with convolutional networks and a composite loss functionBiomedical Signal Processing and Control, 2025
- Amyloid pathology related to aberrant structure-function coupling of brain networks in Alzheimer’s disease: insights from [18F]-florbetapir PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- A whole‐brain functional connectivity model of Alzheimer's disease pathologyAlzheimer's & Dementia, 2024
- Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuumHuman Brain Mapping, 2024
- Machine learning in Alzheimer’s disease drug discovery and target identificationAgeing Research Reviews, 2023
- Whole genome sequencing–based copy number variations reveal novel pathways and targets in Alzheimer's diseaseAlzheimer's & Dementia, 2021
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJAMA, 2020
- Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)Brain Imaging and Behavior, 2012
- Amyloid deposition, hypometabolism, and longitudinal cognitive declineAnnals of Neurology, 2012
- Use of Florbetapir-PET for Imaging β-Amyloid PathologyJAMA, 2011